Cisplatin/5-fluorouracil treatment of recurrent cervical carcinoma: A phase II study with long-term follow-up

Gynecologic Oncology

Volumn 60, Issue 3, 1996, Pages 387-392

  Kaern, Janne ^a   Tropé, Claes ^a   Sundfoer, Kolbein ^a   Kristensen, Gunnar B ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; CISPLATIN; FLUOROURACIL;

ADULT; AGED; ARTICLE; BONE MARROW TOXICITY; CANCER COMBINATION CHEMOTHERAPY; CANCER SURVIVAL; CLINICAL TRIAL; FEMALE; FOLLOW UP; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MAJOR CLINICAL STUDY; NEUROTOXICITY; OTOTOXICITY; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; PROGNOSIS; RECURRENT CANCER; TREATMENT OUTCOME; UTERINE CERVIX CARCINOMA;

EID: 0029913072     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1006/gyno.1996.0059     Document Type: Article

References (17)

1. Bjørge, T., Thoresen, S. Ø., and Skare, B. G. Incidence, survival and mortality in cervical cancer in Norway, 1956-1990, Eur. J. Cancer 29A, 2291-2297 (1993).
2. Perez, C. A., Kuske, R. R., and Camel, H. M. E. Analysis of pelvic tumor control and impact on survival in carcinoma of the uterine cervix treated with radiation therapy alone, Int. J. Radiat. Oncol. Biol. Phys. 14, 613-621 (1988).
3. Vermorken, J. B. The role of chemotherapy in squamous cell carcinoma of the uterine cervix: A review, Int. J. Gynecol. Cancer 3, 129-142 (1993).
4. Bonomi, P., Blessing, J. A., Stehman, F. B., DiSaia, P. J., Walton, L., and Major, F. Randomized trial of three cisplatin dose schedule in squamous-cell carcinoma of the cervix: A gynecologic oncology study, J. Clin. Oncol. 3, 1079-1085 (1985).
5. Kaern, J., Tropé, C., Abeler, V., Iversen, T., and Kjørstad, K. A phase II study of 5-fluorouracil/cisplatinum in recurrent cervical cancer, Acta Oncol 29, 25-28 (1990).
6. Kaplan, E. L., and Meyer, P. Nonparametric estimation from incomplete observations, J. Am. Stat. Assoc. 53, 457-481 (1958).
7. Tarone, R. E., and Ware, J. On distribution-free tests for equality of survival distributions. Biometrika 64, 156-160 (1977).
8. Cox, D. R. Regression models and life labels, J. R. Stat. Soc. [B] 34, 187-220 (1972).
9. Guthrie, D. Chemotherapy of cervical cancer, Clin. Obstet. Gynecol. 12, 229-246 (1985).
10. Freedman, R. S., Herson, J., Wharton, J. T., and Rutledge, F. N. Single-agent chemotherapy for recurrent carcinoma of the cervix, Cancer Clin. Trials 3, 345-350 (1980).
11. Lele, S. B., and Piver, M. S. Weekly cisplatin induction chemotherapy in the treatment of recurrent cervical carcinoma, Gynecol. Oncol. 33, 6-8 (1989).
12. Tropé, C., Horvath, G., Haadem, K., Gudmundsson, T., and Simonsen, E. Doxorubicin-cisplatin combination chemotherapy for recurrent carcinoma of the cervix, Cancer Treat. Rep. 70, 1325-1326 (1986).
13. Malkasian, G. D., Decker, D. G., Green, S. J., Edmonson, J. H., Jefferies, J. A., and Webb, M. J. Treatment of recurrent and metastatic carcinoma of the cervix: Comparison of doxorubicin with a combination of vincristine and 5-fluorouracil, Gynecol. Oncol. 11, 235-239 (1981).
14. Vermorken, J. B., Mangioni, C., Van der Burg, M. E. L., et al. Mitomycin-C/cisplatin (MP) based combination chemotherapy in recurrent and/ or metastatic squamous cell carcinoma of the uterine cervix (SCCUC). The EORTC Gynecological Cancer Cooperative Group (GCCG) experience, Proc. 1st. Meeting Int. Gynecol. Cancer Soc. 31, (1987).
15. Rotmensch, J., Senekhan, E. K., Ghodratollah, J., and Herbot, A. L. Evaluation of bolus cis-platinum and continuous 5-fluorouracil infusion for metastatic and recurrent squamous cell carcinoma of the cervix, Gynecol. Oncol. 29, 76-81 (1988).
16. Bonomi, P., Blessing, J., Ball, H., Hanjani, P., and DiSaia, P. J. A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: A gynecologic oncology group study, Gynecol. Oncol. 34, 357-359 (1989).
17. Alberts, D. S., Kronmal, R., Baker, L. H., Stock-Novack, D. L., Surwit, E. A., Boutselis, J. G., and Hanningan, E. V. Phase II randomized trial of cisplatin chemotherapy regiments in the treatment of metastatic squamous cell cancer of the cervix: A southwest Oncology Group study, J. Clin. Oncol. 5, 1791-1795 (1987).